Utility of combined CD39/CD73/CD38 expression for the detection of malignant T cells in Sezary syndrome. Marchisio S, Yakymiv Y, Lin L, Ortolan E, et al. Br J Haematol 2026;209:42-53.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Marchisio S, Yakymiv Y, Lin L, Ortolan E, et al. Utility of combined CD39/CD73/CD38 expression for the detection of malignant T cells in Sezary syndrome. Br J Haematol 2026;209:42-53.
PMID: 42179066